fbpx
logo of ctsdatabase

CASE STUDY

logo of ctsdatabase

CASE STUDY

Background

In the United States of America, pharmaceutical companies pay human volunteers for testing their drugs. These clinical trials use groups of individuals to understand the side effects and impacts of certain drugs on people over a period of time.

The
Problem

Participants are not allowed to volunteer in multiple clinical trials simultaneously. However, volunteers sign-up with many clinical trials for more money, rendering the trial results inaccurate. CTSdatabase, LLC, a US based clinical trials company, engaged with Southtech Limited in 2012 to help screen out such duplicate volunteers

Southtech developed a simple and secure ‘trial subject database’ for CTSdatabase through which investigators and pharmaceutical companies can screen out the individuals who have or are participating with multiple investigators. Before this solution, the Clinical Trials market did not have any means of catching dishonest customers.

The
Solution​

Expanding the reach

Southtech has further expanded CTSdatabase platform’s capabilities, by creating the most ambitious of their feature rollouts – an API (Application Programming Interface) framework to communicate with another subject registry.  Southtech built an additional application called SubjectRegistry, a standard platform for interacting with CTS and another subject registry. This new infrastructure has allowed pharmaceutical companies to obtain data from multiple duplication registries by entering the data only once.

Benefits

Approximately 20 pharmaceutical companies from the US, EU and the Asia Pacific region have used CTSdatabase’s platform developed by Southtech to protect their studies, saving them ~200 million dollars over the course of 8 years.

>100

Clinical studies completed between 2012 and 2020​

12

Months to profit

<5

Minutes to verify

7%

Hit rate

Benefits

Approximately 20 pharmaceutical companies from the US, EU and the Asia Pacific region have used CTSdatabase’s platform developed by Southtech to protect their studies, saving them ~200 million dollars over the course of 8 years.

>100

Clinical studies completed between 2012 and 2020​

12

Months to profit

<5

Minutes to verify

7%

Hit rate

How Can We Help You?

We can help you from automating your HR to implementing UX/UI design solutions for your organization

Requesting demo

Ascend Financials logo